"Antibody could be used to treat type 2 diabetes, Harvard researchers report"
January 9, 2016
"An antibody that is capable of improving glucose regulation and reducing fatty liver disease could be used to treat type 2 diabetes, according to new research.
The antibody, created by researchers at the Harvard T.H. Chan School of Public Health, targets the hormone aP2 (also known as FABP4), a fatty acid binding protein which is located in adipose (fat) storing tissues."